Triple-negative breast cancer (TNBC), which negatively expresses estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), is a distinctive subcategory of breast cancer [7]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.